25 XP   0   0   10

Amgen Inc.
Buy, Hold or Sell?

Let's analyse Amgen Inc. together

PenkeI guess you are interested in Amgen Inc.. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Amgen Inc.. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Amgen Inc.

I send you an email if I find something interesting about Amgen Inc..

Quick analysis of Amgen Inc. (30 sec.)










What can you expect buying and holding a share of Amgen Inc.? (30 sec.)

How much money do you get?

How much money do you get?
‚ā¨8.64
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
‚ā¨8.75
Expected worth in 1 year
‚ā¨8.15
How sure are you?
72.2%

+ What do you gain per year?

Total Gains per Share
‚ā¨7.47
Return On Investment
2.7%

For what price can you sell your share?

Current Price per Share
‚ā¨277.85
Expected price per share
‚ā¨261.99 - ‚ā¨292.60
How sure are you?
50%

1. Valuation of Amgen Inc. (5 min.)




Live pricePrice per Share (EOD)

‚ā¨277.85

Intrinsic Value Per Share

‚ā¨-7.12 - ‚ā¨-14.55

Total Value Per Share

‚ā¨1.63 - ‚ā¨-5.80

2. Growth of Amgen Inc. (5 min.)




Is Amgen Inc. growing?

Current yearPrevious yearGrowGrow %
How rich?$5b$3.7b$2.6b41.3%

How much money is Amgen Inc. making?

Current yearPrevious yearGrowGrow %
Making money$940.7m$1.9b-$1b-110.4%
Net Profit Margin13.2%30.6%--

How much money comes from the company's main activities?

3. Financial Health of Amgen Inc. (5 min.)




4. Comparing to competitors in the Other industry (5 min.)




  Industry Rankings (Other)  


Richest
#48 / 394

Most Revenue
#28 / 394

Most Profit
#18 / 394

What can you expect buying and holding a share of Amgen Inc.? (5 min.)

Welcome investor! Amgen Inc.'s management wants to use your money to grow the business. In return you get a share of Amgen Inc..

What can you expect buying and holding a share of Amgen Inc.?

First you should know what it really means to hold a share of Amgen Inc.. And how you can make/lose money.

Speculation

The Price per Share of Amgen Inc. is ‚ā¨277.85. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Amgen Inc..
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Amgen Inc., you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ‚ā¨8.75. Based on the TTM, the Book Value Change Per Share is ‚ā¨-0.15 per quarter. Based on the YOY, the Book Value Change Per Share is ‚ā¨1.94 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ‚ā¨2.02 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Amgen Inc..

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ‚ā¨% of Price per Share‚ā¨% of Price per Share‚ā¨% of Price per Share‚ā¨% of Price per Share‚ā¨% of Price per Share
Usd Eps-0.21-0.1%1.760.6%3.711.3%2.520.9%2.400.9%
Usd Book Value Change Per Share-2.27-0.8%-0.16-0.1%2.070.7%0.520.2%0.520.2%
Usd Dividend Per Share2.250.8%2.160.8%1.990.7%1.870.7%1.870.7%
Usd Total Gains Per Share-0.020.0%2.000.7%4.061.5%2.390.9%2.390.9%
Usd Price Per Share282.72-263.28-249.36-229.30-226.90-
Price to Earnings Ratio-335.21--61.07-18.40-2.83-2.70-
Price-to-Total Gains Ratio-18,844.98--4,811.05-72.50--535.65--535.65-
Price to Book Ratio30.17-22.61-38.34-25.15-23.96-
Price-to-Total Gains Ratio-18,844.98--4,811.05-72.50--535.65--535.65-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share297.549565
Number of shares3
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share2.161.87
Usd Book Value Change Per Share-0.160.52
Usd Total Gains Per Share2.002.39
Gains per Quarter (3 shares)6.007.16
Gains per Year (3 shares)24.0128.64
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
126-21422619
252-438451248
378-662671977
4104-8869025106
5130-1011011231135
6156-1113413437164
7182-1315815744193
8207-1518217950222
9233-1720620256251
10259-1923022462280

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share3.01.00.075.0%11.01.00.091.7%17.01.00.094.4%17.01.00.094.4%17.01.00.094.4%
Book Value Change Per Share2.02.00.050.0%7.05.00.058.3%10.08.00.055.6%10.08.00.055.6%10.08.00.055.6%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%18.00.00.0100.0%18.00.00.0100.0%18.00.00.0100.0%
Total Gains per Share2.02.00.050.0%8.04.00.066.7%13.05.00.072.2%13.05.00.072.2%13.05.00.072.2%

Fundamentals of Amgen Inc.

About Amgen Inc.

  • Other
  • 0

There is no Profile data available for AMG.BE.

Fundamental data was last updated by Penke on 2024-06-07 17:12:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is overpriced.

1.1. Profitability of Amgen Inc..

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit¬†Amgen Inc. earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare¬†Amgen Inc. to the¬†Other industry mean.
  • A Net Profit Margin of -1.5%¬†means that¬†€-0.02 for each €1¬†in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Amgen Inc.:

  • The MRQ is -1.5%. The company is making a loss. -1
  • The TTM is 13.2%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ-1.5%TTM13.2%-14.7%
TTM13.2%YOY30.6%-17.4%
TTM13.2%5Y25.1%-12.0%
5Y25.1%10Y25.7%-0.5%
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.5%5.6%-7.1%
TTM13.2%5.0%+8.2%
YOY30.6%6.0%+24.6%
5Y25.1%6.0%+19.1%
10Y25.7%6.1%+19.6%
1.1.2. Return on Assets

Shows how efficient Amgen Inc. is using its assets to generate profit.

  • Above 5% is considered healthy¬†but always compare¬†Amgen Inc. to the¬†Other industry mean.
  • -0.1% Return on Assets means that¬†Amgen Inc. generated¬†€0.00 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Amgen Inc.:

  • The MRQ is -0.1%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is 1.0%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ-0.1%TTM1.0%-1.1%
TTM1.0%YOY2.8%-1.8%
TTM1.0%5Y2.4%-1.4%
5Y2.4%10Y2.5%0.0%
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.1%1.1%-1.2%
TTM1.0%1.0%+0.0%
YOY2.8%1.5%+1.3%
5Y2.4%1.1%+1.3%
10Y2.5%1.3%+1.2%
1.1.3. Return on Equity

Shows how efficient Amgen Inc. is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare¬†Amgen Inc. to the¬†Other industry mean.
  • -2.3% Return on Equity means Amgen Inc. generated €-0.02¬†for each¬†€1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Amgen Inc.:

  • The MRQ is -2.3%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is 13.2%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ-2.3%TTM13.2%-15.5%
TTM13.2%YOY52.6%-39.3%
TTM13.2%5Y31.3%-18.1%
5Y31.3%10Y30.7%+0.6%
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.3%3.4%-5.7%
TTM13.2%3.2%+10.0%
YOY52.6%4.7%+47.9%
5Y31.3%3.7%+27.6%
10Y30.7%3.7%+27.0%

1.2. Operating Efficiency of Amgen Inc..

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Amgen Inc. is operating .

  • Measures how much profit Amgen Inc. makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare¬†Amgen Inc. to the¬†Other industry mean.
  • An Operating Margin of 0.0%¬†means the company generated €0.00 ¬†for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Amgen Inc.:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y18.2%-18.2%
5Y18.2%10Y20.1%-1.8%
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ-9.6%-9.6%
TTM-9.6%-9.6%
YOY-8.7%-8.7%
5Y18.2%5.7%+12.5%
10Y20.1%7.1%+13.0%
1.2.2. Operating Ratio

Measures how efficient Amgen Inc. is keeping operating costs low.

  • Below 1 is considered healthy (always compare to¬†Other industry mean).
  • An Operation Ratio of 1.30 means that the operating costs are €1.30 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Amgen Inc.:

  • The MRQ is 1.297. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.091. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.297TTM1.091+0.205
TTM1.091YOY0.909+0.183
TTM1.0915Y0.915+0.176
5Y0.91510Y0.907+0.008
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2971.227+0.070
TTM1.0911.253-0.162
YOY0.9091.242-0.333
5Y0.9151.258-0.343
10Y0.9071.360-0.453

1.3. Liquidity of Amgen Inc..

1.3. Liquidity
1.3.1. Current Ratio

Measures if Amgen Inc. is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to¬†Other industry mean).
  • A Current Ratio of 1.42¬†means the company has €1.42 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Amgen Inc.:

  • The MRQ is 1.422. The company is just able to pay all its short-term debts.
  • The TTM is 2.175. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.422TTM2.175-0.754
TTM2.175YOY1.942+0.233
TTM2.1755Y1.959+0.216
5Y1.95910Y1.998-0.038
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ1.4221.411+0.011
TTM2.1751.515+0.660
YOY1.9421.541+0.401
5Y1.9591.538+0.421
10Y1.9981.493+0.505
1.3.2. Quick Ratio

Measures if Amgen Inc. is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but¬†always compare¬†Amgen Inc. to the¬†Other industry mean.
  • A Quick Ratio of 0.34¬†means the company can pay off €0.34 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Amgen Inc.:

  • The MRQ is 0.344. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.361. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.344TTM0.361-0.017
TTM0.361YOY0.488-0.128
TTM0.3615Y0.600-0.239
5Y0.60010Y0.657-0.057
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3440.550-0.206
TTM0.3610.570-0.209
YOY0.4880.578-0.090
5Y0.6000.603-0.003
10Y0.6570.603+0.054

1.4. Solvency of Amgen Inc..

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Amgen Inc. assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare¬†Amgen Inc. to Other industry mean.
  • A Debt to Asset Ratio of 0.95¬†means that Amgen Inc. assets are¬†financed with 94.6% credit (debt) and the remaining percentage (100% - 94.6%)¬†is financed by its owners/shareholders.¬†

Let's take a look of the Debt to Asset Ratio trends of Amgen Inc.:

  • The MRQ is 0.946. The company is just able to pay all its debts by selling its assets.
  • The TTM is 0.931. The company is just able to pay all its debts by selling its assets.
Trends
Current periodCompared to+/- 
MRQ0.946TTM0.931+0.015
TTM0.931YOY0.946-0.016
TTM0.9315Y0.890+0.040
5Y0.89010Y0.887+0.003
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9460.531+0.415
TTM0.9310.527+0.404
YOY0.9460.560+0.386
5Y0.8900.562+0.328
10Y0.8870.569+0.318
1.4.2. Debt to Equity Ratio

Measures if Amgen Inc. is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but¬†always compare¬†Amgen Inc. to the¬†Other industry mean.
  • A Debt to Equity ratio of 1,751.5% means that company has €17.51 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Amgen Inc.:

  • The MRQ is 17.515. The company is unable to pay all its debts with equity. -1
  • The TTM is 13.810. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ17.515TTM13.810+3.704
TTM13.810YOY18.082-4.271
TTM13.8105Y12.674+1.136
5Y12.67410Y12.305+0.370
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ17.5151.113+16.402
TTM13.8101.112+12.698
YOY18.0821.272+16.810
5Y12.6741.333+11.341
10Y12.3051.473+10.832

2. Market Valuation of Amgen Inc.

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures¬†how much money you pay¬†for each share for¬†every €1 in earnings Amgen Inc. generates.

  • Above 15 is considered overpriced but¬†always compare¬†Amgen Inc. to the¬†Other industry mean.
  • A PE ratio of -335.21 means the investor is paying €-335.21¬†for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Amgen Inc.:

  • The EOD is -352.791. Based on the earnings, the company is expensive. -2
  • The MRQ is -335.205. Based on the earnings, the company is expensive. -2
  • The TTM is -61.068. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-352.791MRQ-335.205-17.586
MRQ-335.205TTM-61.068-274.137
TTM-61.068YOY18.400-79.468
TTM-61.0685Y2.833-63.901
5Y2.83310Y2.698+0.135
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
EOD-352.79113.582-366.373
MRQ-335.20511.135-346.340
TTM-61.06810.480-71.548
YOY18.40011.329+7.071
5Y2.83311.709-8.876
10Y2.69812.634-9.936
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Amgen Inc.:

  • The EOD is 86.853. Based on how much money comes from the company's main activities, the company is overpriced. -1
  • The MRQ is 82.523. Based on how much money comes from the company's main activities, the company is overpriced. -1
  • The TTM is 58.439. Based on how much money comes from the company's main activities, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD86.853MRQ82.523+4.329
MRQ82.523TTM58.439+24.084
TTM58.439YOY21.890+36.549
TTM58.4395Y23.081+35.358
5Y23.08110Y21.982+1.099
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
EOD86.8535.586+81.267
MRQ82.5235.190+77.333
TTM58.4394.831+53.608
YOY21.8901.966+19.924
5Y23.0812.318+20.763
10Y21.9823.588+18.394
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Amgen Inc. is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy¬†(always compare to Other industry mean).
  • A PB ratio of 30.17 means the investor is paying €30.17¬†for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Amgen Inc.:

  • The EOD is 31.753. Based on the equity, the company is expensive. -2
  • The MRQ is 30.170. Based on the equity, the company is expensive. -2
  • The TTM is 22.609. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD31.753MRQ30.170+1.583
MRQ30.170TTM22.609+7.561
TTM22.609YOY38.336-15.727
TTM22.6095Y25.155-2.545
5Y25.15510Y23.957+1.198
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
EOD31.7531.648+30.105
MRQ30.1701.273+28.897
TTM22.6091.304+21.305
YOY38.3361.387+36.949
5Y25.1551.516+23.639
10Y23.9571.635+22.322
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Amgen Inc. compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---2.119-0.149-93%1.936-209%0.486-536%0.486-536%
Book Value Per Share--8.75011.205-22%6.591+33%10.314-15%9.823-11%
Current Ratio--1.4222.175-35%1.942-27%1.959-27%1.998-29%
Debt To Asset Ratio--0.9460.931+2%0.9460%0.890+6%0.887+7%
Debt To Equity Ratio--17.51513.810+27%18.082-3%12.674+38%12.305+42%
Dividend Per Share--2.1052.018+4%1.859+13%1.742+21%1.742+21%
Eps---0.1971.642-112%3.460-106%2.351-108%2.239-109%
Free Cash Flow Per Share--0.8003.097-74%3.469-77%3.519-77%3.519-77%
Free Cash Flow To Equity Per Share---2.1762.151-201%12.640-117%3.639-160%3.639-160%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---14.550--------
Intrinsic Value_10Y_min---7.121--------
Intrinsic Value_1Y_max--11.414--------
Intrinsic Value_1Y_min--11.219--------
Intrinsic Value_3Y_max--24.485--------
Intrinsic Value_3Y_min--23.574--------
Intrinsic Value_5Y_max--25.729--------
Intrinsic Value_5Y_min--24.725--------
Market Cap--141482589864.000131617727466.000+7%124381708750.000+14%109271426543.200+29%104068025279.238+36%
Net Profit Margin---0.0150.132-112%0.306-105%0.251-106%0.257-106%
Operating Margin----0%-0%0.182-100%0.201-100%
Operating Ratio--1.2971.091+19%0.909+43%0.915+42%0.907+43%
Pb Ratio31.753+5%30.17022.609+33%38.336-21%25.155+20%23.957+26%
Pe Ratio-352.791-5%-335.205-61.068-82%18.400-1922%2.833-11933%2.698-12525%
Price Per Share277.850+5%264.000245.850+7%232.850+13%214.119+23%211.879+25%
Price To Free Cash Flow Ratio86.853+5%82.52358.439+41%21.890+277%23.081+258%21.982+275%
Price To Total Gains Ratio-19833.624-5%-18844.977-4811.055-74%72.497-26094%-535.646-97%-535.646-97%
Quick Ratio--0.3440.361-5%0.488-30%0.600-43%0.657-48%
Return On Assets---0.0010.010-112%0.028-104%0.024-105%0.025-105%
Return On Equity---0.0230.132-117%0.526-104%0.313-107%0.307-107%
Total Gains Per Share---0.0141.869-101%3.795-100%2.229-101%2.229-101%
Usd Book Value--5022032241.2406422791234.055-22%3770274205.005+33%7304646895.532-31%7472619402.480-33%
Usd Book Value Change Per Share---2.269-0.160-93%2.074-209%0.521-536%0.521-536%
Usd Book Value Per Share--9.37111.999-22%7.059+33%11.045-15%10.519-11%
Usd Dividend Per Share--2.2542.161+4%1.990+13%1.866+21%1.866+21%
Usd Eps---0.2111.758-112%3.706-106%2.517-108%2.397-109%
Usd Free Cash Flow--459002946.7801774511392.290-74%1984262738.885-77%2113613569.312-78%2095299166.020-78%
Usd Free Cash Flow Per Share--0.8563.316-74%3.715-77%3.769-77%3.769-77%
Usd Free Cash Flow To Equity Per Share---2.3312.303-201%13.536-117%3.897-160%3.897-160%
Usd Market Cap--151513705485.358140949424343.339+7%133200371900.375+14%117018770685.113+29%111446448271.536+36%
Usd Price Per Share297.550+5%282.718263.281+7%249.359+13%229.300+23%226.901+25%
Usd Profit---113000725.460940756039.615-112%1979262706.785-106%1608160324.323-107%1626439013.100-107%
Usd Revenue--7447047809.7407383047398.860+1%6547542034.950+14%6558442104.928+14%6510756084.500+14%
Usd Total Gains Per Share---0.0152.001-101%4.064-100%2.387-101%2.387-101%
 EOD+2 -4MRQTTM+7 -27YOY+13 -215Y+7 -2810Y+7 -28

3.2. Fundamental Score

Let's check the fundamental score of Amgen Inc. based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-352.791
Price to Book Ratio (EOD)Between0-131.753
Net Profit Margin (MRQ)Greater than0-0.015
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.344
Current Ratio (MRQ)Greater than11.422
Debt to Asset Ratio (MRQ)Less than10.946
Debt to Equity Ratio (MRQ)Less than117.515
Return on Equity (MRQ)Greater than0.15-0.023
Return on Assets (MRQ)Greater than0.05-0.001
Total2/10 (20.0%)

3.3. Technical Score

Let's check the technical score of Amgen Inc. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5048.715
Ma 20Greater thanMa 50281.178
Ma 50Greater thanMa 100271.205
Ma 100Greater thanMa 200267.623
OpenGreater thanClose277.850
Total3/5 (60.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2023-03-312023-06-302023-09-302023-12-312024-03-31
Income before Tax  3,214,140-1,706,9861,507,153310,9551,818,109-1,022,511795,598-859,096-63,498
Net Income  2,652,926-1,365,2161,287,710327,7641,615,474-899,249716,225-821,744-105,519
Net Income from Continuing Operations  2,652,926-1,365,2161,287,710327,7641,615,474-899,249716,225-821,744-105,519



Latest Balance Sheet

Balance Sheet of 2024-03-31. Currency in USD. All numbers in thousands.

Summary
Total Assets92,980,000
Total Liabilities87,958,000
Total Stockholder Equity5,022,000
 As reported
Total Liabilities 87,958,000
Total Stockholder Equity+ 5,022,000
Total Assets = 92,980,000

Assets

Total Assets92,980,000
Total Current Assets28,029,000
Long-term Assets64,951,000
Total Current Assets
Cash And Cash Equivalents 9,708,000
Net Receivables 6,776,000
Inventory 8,724,000
Other Current Assets 2,821,000
Total Current Assets  (as reported)28,029,000
Total Current Assets  (calculated)28,029,000
+/-0
Long-term Assets
Property Plant Equipment 6,002,000
Goodwill 18,570,000
Intangible Assets 31,372,000
Long-term Assets Other 9,007,000
Long-term Assets  (as reported)64,951,000
Long-term Assets  (calculated)64,951,000
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities19,714,000
Long-term Liabilities68,244,000
Total Stockholder Equity5,022,000
Total Current Liabilities
Short Long Term Debt 3,959,000
Accounts payable 1,628,000
Total Current Liabilities  (as reported)19,714,000
Total Current Liabilities  (calculated)5,587,000
+/- 14,127,000
Long-term Liabilities
Long term Debt 60,061,000
Long-term Liabilities Other 2,357,000
Long-term Liabilities  (as reported)68,244,000
Long-term Liabilities  (calculated)62,418,000
+/- 5,826,000
Total Stockholder Equity
Total Stockholder Equity (as reported)5,022,000
Total Stockholder Equity (calculated)0
+/- 5,022,000
Other
Capital Stock33,082,000
Common Stock Shares Outstanding 535,919
Net Debt 54,312,000
Net Invested Capital 69,042,000
Net Working Capital 8,315,000



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-31
> Total Assets 
63,997,000
59,373,000
59,535,000
59,707,000
61,669,000
65,011,000
64,637,000
62,948,000
62,539,000
59,773,000
64,993,000
61,165,000
59,196,000
59,294,000
63,700,000
65,121,000
88,720,000
90,269,000
90,534,000
97,154,000
92,980,000
92,980,00097,154,00090,534,00090,269,00088,720,00065,121,00063,700,00059,294,00059,196,00061,165,00064,993,00059,773,00062,539,00062,948,00064,637,00065,011,00061,669,00059,707,00059,535,00059,373,00063,997,000
   > Total Current Assets 
35,151,000
30,746,000
31,051,000
18,440,000
18,813,000
22,895,000
22,661,000
21,144,000
21,299,000
19,099,000
24,380,000
19,385,000
18,520,000
19,322,000
24,062,000
22,186,000
44,703,000
47,380,000
48,477,000
30,332,000
28,029,000
28,029,00030,332,00048,477,00047,380,00044,703,00022,186,00024,062,00019,322,00018,520,00019,385,00024,380,00019,099,00021,299,00021,144,00022,661,00022,895,00018,813,00018,440,00031,051,00030,746,00035,151,000
       Cash And Cash Equivalents 
7,358,000
5,525,000
11,415,000
6,037,000
7,687,000
9,145,000
9,087,000
6,266,000
6,112,000
6,630,000
11,969,000
7,989,000
6,528,000
5,203,000
9,502,000
7,629,000
31,560,000
34,248,000
34,741,000
10,944,000
9,708,000
9,708,00010,944,00034,741,00034,248,00031,560,0007,629,0009,502,0005,203,0006,528,0007,989,00011,969,0006,630,0006,112,0006,266,0009,087,0009,145,0007,687,0006,037,00011,415,0005,525,0007,358,000
       Short-term Investments 
18,943,000
16,233,000
9,438,000
2,874,000
325,000
2,276,000
3,273,000
4,381,000
4,454,000
1,452,000
952,000
48,000
16,000
1,980,000
1,976,000
1,676,000
1,000
0
0
0
0
00001,0001,676,0001,976,0001,980,00016,00048,000952,0001,452,0004,454,0004,381,0003,273,0002,276,000325,0002,874,0009,438,00016,233,00018,943,000
       Net Receivables 
3,771,000
3,801,000
3,606,000
4,057,000
5,009,000
5,366,000
4,094,000
4,525,000
4,423,000
4,479,000
4,765,000
4,895,000
5,077,000
5,327,000
5,326,000
5,563,000
5,736,000
5,830,000
6,145,000
7,268,000
6,776,000
6,776,0007,268,0006,145,0005,830,0005,736,0005,563,0005,326,0005,327,0005,077,0004,895,0004,765,0004,479,0004,423,0004,525,0004,094,0005,366,0005,009,0004,057,0003,606,0003,801,0003,771,000
       Inventory 
3,016,000
3,176,000
3,243,000
3,584,000
3,682,000
3,840,000
3,942,000
3,893,000
4,017,000
4,115,000
4,152,000
4,086,000
4,411,000
4,554,000
4,757,000
4,930,000
5,011,000
4,978,000
5,026,000
9,518,000
8,724,000
8,724,0009,518,0005,026,0004,978,0005,011,0004,930,0004,757,0004,554,0004,411,0004,086,0004,152,0004,115,0004,017,0003,893,0003,942,0003,840,0003,682,0003,584,0003,243,0003,176,0003,016,000
       Other Current Assets 
2,063,000
2,011,000
3,349,000
1,888,000
2,110,000
2,268,000
2,265,000
2,079,000
2,293,000
2,423,000
2,542,000
2,367,000
2,488,000
2,258,000
2,501,000
355,000
2,395,000
2,324,000
2,565,000
281,000
2,821,000
2,821,000281,0002,565,0002,324,0002,395,000355,0002,501,0002,258,0002,488,0002,367,0002,542,0002,423,0002,293,0002,079,0002,265,0002,268,0002,110,0001,888,0003,349,0002,011,0002,063,000
   > Long-term Assets 
28,846,000
28,627,000
28,484,000
41,267,000
42,856,000
42,116,000
41,976,000
41,804,000
41,240,000
40,674,000
40,613,000
41,780,000
40,676,000
39,972,000
39,638,000
42,935,000
44,017,000
42,889,000
42,057,000
66,822,000
64,951,000
64,951,00066,822,00042,057,00042,889,00044,017,00042,935,00039,638,00039,972,00040,676,00041,780,00040,613,00040,674,00041,240,00041,804,00041,976,00042,116,00042,856,00041,267,00028,484,00028,627,00028,846,000
       Property Plant Equipment 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,188,000
5,427,000
5,460,000
5,532,000
5,563,000
5,941,000
6,002,000
6,002,0005,941,0005,563,0005,532,0005,460,0005,427,0005,188,00000000000000000
       Goodwill 
14,692,000
14,689,000
14,705,000
14,703,000
14,683,000
14,678,000
14,674,000
14,689,000
14,673,000
14,676,000
14,665,000
14,890,000
14,897,000
14,865,000
14,845,000
15,529,000
15,531,000
15,531,000
15,509,000
18,629,000
18,570,000
18,570,00018,629,00015,509,00015,531,00015,531,00015,529,00014,845,00014,865,00014,897,00014,890,00014,665,00014,676,00014,673,00014,689,00014,674,00014,678,00014,683,00014,703,00014,705,00014,689,00014,692,000
       Intangible Assets 
7,124,000
6,813,000
6,702,000
19,413,000
18,653,000
17,948,000
17,254,000
16,587,000
15,947,000
15,308,000
14,659,000
15,182,000
14,567,000
13,927,000
13,266,000
16,080,000
15,393,000
14,633,000
13,150,000
32,641,000
31,372,000
31,372,00032,641,00013,150,00014,633,00015,393,00016,080,00013,266,00013,927,00014,567,00015,182,00014,659,00015,308,00015,947,00016,587,00017,254,00017,948,00018,653,00019,413,0006,702,0006,813,0007,124,000
       Long-term Assets Other 
2,138,000
2,243,000
2,176,000
2,223,000
4,641,000
4,647,000
5,232,000
5,639,000
5,765,000
5,784,000
6,307,000
6,524,000
6,070,000
6,022,000
6,339,000
5,899,000
7,633,000
7,193,000
7,835,000
9,611,000
9,007,000
9,007,0009,611,0007,835,0007,193,0007,633,0005,899,0006,339,0006,022,0006,070,0006,524,0006,307,0005,784,0005,765,0005,639,0005,232,0004,647,0004,641,0002,223,0002,176,0002,243,0002,138,000
> Total Liabilities 
53,165,000
48,579,000
48,608,000
50,034,000
52,184,000
54,352,000
53,678,000
53,539,000
53,205,000
51,526,000
56,776,000
54,465,000
58,280,000
56,875,000
60,047,000
61,460,000
83,372,000
83,488,000
82,878,000
90,922,000
87,958,000
87,958,00090,922,00082,878,00083,488,00083,372,00061,460,00060,047,00056,875,00058,280,00054,465,00056,776,00051,526,00053,205,00053,539,00053,678,00054,352,00052,184,00050,034,00048,608,00048,579,00053,165,000
   > Total Current Liabilities 
12,706,000
10,622,000
10,737,000
12,835,000
11,827,000
10,523,000
9,953,000
11,653,000
12,869,000
14,585,000
14,842,000
12,184,000
12,886,000
12,618,000
14,331,000
15,687,000
14,215,000
17,097,000
16,954,000
18,392,000
19,714,000
19,714,00018,392,00016,954,00017,097,00014,215,00015,687,00014,331,00012,618,00012,886,00012,184,00014,842,00014,585,00012,869,00011,653,0009,953,00010,523,00011,827,00012,835,00010,737,00010,622,00012,706,000
       Short-term Debt 
3,705,000
2,816,000
2,049,000
2,953,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000002,953,0002,049,0002,816,0003,705,000
       Short Long Term Debt 
3,705,000
2,816,000
2,049,000
2,953,000
1,840,000
91,000
91,000
91,000
1,556,000
4,324,000
4,288,000
87,000
844,000
817,000
1,543,000
1,591,000
834,000
2,167,000
1,428,000
1,443,000
3,959,000
3,959,0001,443,0001,428,0002,167,000834,0001,591,0001,543,000817,000844,00087,0004,288,0004,324,0001,556,00091,00091,00091,0001,840,0002,953,0002,049,0002,816,0003,705,000
       Accounts payable 
1,091,000
1,001,000
1,005,000
1,371,000
1,338,000
1,150,000
1,161,000
1,421,000
1,396,000
1,277,000
1,171,000
1,366,000
1,403,000
1,256,000
1,204,000
1,572,000
1,320,000
1,212,000
1,358,000
1,590,000
1,628,000
1,628,0001,590,0001,358,0001,212,0001,320,0001,572,0001,204,0001,256,0001,403,0001,366,0001,171,0001,277,0001,396,0001,421,0001,161,0001,150,0001,338,0001,371,0001,005,0001,001,0001,091,000
   > Long-term Liabilities 
40,459,000
37,957,000
37,871,000
37,199,000
40,357,000
43,829,000
43,725,000
41,886,000
40,336,000
36,941,000
41,934,000
42,281,000
45,394,000
44,257,000
45,716,000
45,773,000
69,157,000
66,391,000
65,924,000
72,530,000
68,244,000
68,244,00072,530,00065,924,00066,391,00069,157,00045,773,00045,716,00044,257,00045,394,00042,281,00041,934,00036,941,00040,336,00041,886,00043,725,00043,829,00040,357,00037,199,00037,871,00037,957,00040,459,000
       Long term Debt 
29,319,000
27,798,000
27,742,000
26,950,000
30,008,000
34,133,000
34,196,000
32,895,000
31,129,000
28,458,000
33,291,000
33,222,000
36,010,000
35,705,000
37,161,000
37,354,000
60,761,000
59,377,000
59,040,000
63,170,000
60,061,000
60,061,00063,170,00059,040,00059,377,00060,761,00037,354,00037,161,00035,705,00036,010,00033,222,00033,291,00028,458,00031,129,00032,895,00034,196,00034,133,00030,008,00026,950,00027,742,00027,798,00029,319,000
       Long-term Liabilities Other 
1,460,000
1,535,000
1,543,000
1,606,000
1,811,000
1,881,000
1,759,000
2,023,000
2,170,000
2,055,000
2,160,000
2,465,000
2,732,000
2,949,000
2,875,000
2,651,000
2,532,000
2,536,000
2,305,000
2,326,000
2,357,000
2,357,0002,326,0002,305,0002,536,0002,532,0002,651,0002,875,0002,949,0002,732,0002,465,0002,160,0002,055,0002,170,0002,023,0001,759,0001,881,0001,811,0001,606,0001,543,0001,535,0001,460,000
> Total Stockholder Equity
10,832,000
10,794,000
10,927,000
9,673,000
9,485,000
10,659,000
10,959,000
9,409,000
9,334,000
8,247,000
8,217,000
6,700,000
916,000
2,419,000
3,653,000
3,661,000
5,348,000
6,781,000
7,656,000
6,232,000
5,022,000
5,022,0006,232,0007,656,0006,781,0005,348,0003,661,0003,653,0002,419,000916,0006,700,0008,217,0008,247,0009,334,0009,409,00010,959,00010,659,0009,485,0009,673,00010,927,00010,794,00010,832,000
   Common Stock000000000000000000000
   Retained Earnings Total Equity000000000000000000000
   Accumulated Other Comprehensive Income 000000000000000000000
   Capital Surplus 000000000000000000000
   Treasury Stock000000000000000000000
   Other Stockholders Equity 000000000000000000000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue28,190,000
Cost of Revenue-8,451,000
Gross Profit19,739,00019,739,000
 
Operating Income (+$)
Gross Profit19,739,000
Operating Expense-20,293,000
Operating Income7,897,000-554,000
 
Operating Expense (+$)
Research Development4,784,000
Selling General Administrative6,179,000
Selling And Marketing Expenses0
Operating Expense20,293,00010,963,000
 
Net Interest Income (+$)
Interest Income0
Interest Expense-2,875,000
Other Finance Cost-0
Net Interest Income-2,875,000
 
Pretax Income (+$)
Operating Income7,897,000
Net Interest Income-2,875,000
Other Non-Operating Income Expenses0
Income Before Tax (EBT)7,855,0005,064,000
EBIT - interestExpense = -2,875,000
6,717,000
9,592,000
Interest Expense2,875,000
Earnings Before Interest and Taxes (EBIT)010,730,000
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax7,855,000
Tax Provision-1,138,000
Net Income From Continuing Ops6,717,0006,717,000
Net Income6,717,000
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net2,833,0002,875,000
 

Technical Analysis of Amgen Inc.
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Amgen Inc.. The general trend of Amgen Inc. is BULLISH with 57.1% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Amgen Inc.'s overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (57.1%) Bearish trend (-57.1%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Amgen Inc..

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 292.60.

The bearish price targets are: 272.45 > 264.57 > 261.99.

Tweet this
Amgen Inc. Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging¬†trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Amgen Inc.. The current mas is .

The long score for the Moving Averages is 11/14.
The longshort score for the Moving Averages is 8/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Amgen Inc. Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a¬†lagging momentum¬†indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Amgen Inc.. The current macd is 1.24978238.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Amgen Inc. price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Amgen Inc.. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Amgen Inc. price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Amgen Inc. Daily Moving Average Convergence/Divergence (MACD) ChartAmgen Inc. Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Amgen Inc.. The current adx is 13.69.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Amgen Inc. shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Amgen Inc. Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows¬†the current trend.
  • Shows¬†potential entry signals.
  • Shows¬†¬†potential exit signals.
  • Can be used to place¬†trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Amgen Inc.. The current sar is 283.06.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Amgen Inc. Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum¬†indicator, meaning the signals are instant.
  • Ranges¬†between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Amgen Inc.. The current rsi is 48.72. The current phase is Correction in bull market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Correction in bull market: Moderate price decline, potential pause in the uptrend. Reassess the market, wait for signs of stabilization.
  • Trending down: The RSI is trending down. -1
Amgen Inc. Daily Relative Strength Index (RSI) ChartAmgen Inc. Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading¬†momentum¬†indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges¬†between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Amgen Inc.. The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -2/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Amgen Inc. price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Amgen Inc. Daily Stochastic Oscillator ChartAmgen Inc. Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,¬†the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Amgen Inc.. The current cci is -68.92288673.

Amgen Inc. Daily Commodity Channel Index (CCI) ChartAmgen Inc. Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Amgen Inc.. The current cmo is -12.94389238.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Amgen Inc. Daily Chande Momentum Oscillator (CMO) ChartAmgen Inc. Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and¬†-100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Amgen Inc.. The current willr is -47.57281553.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Amgen Inc. is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Amgen Inc. Daily Williams %R ChartAmgen Inc. Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold¬†

Score

Let's take a look at the Bollinger Bands of Amgen Inc..

Amgen Inc. Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Amgen Inc.. The current atr is 2.67612458.

Amgen Inc. Daily Average True Range (ATR) ChartAmgen Inc. Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Amgen Inc.. The current obv is 1,246.

Amgen Inc. Daily On-Balance Volume (OBV) ChartAmgen Inc. Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Amgen Inc.. The current mfi is 35.89.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Amgen Inc. Daily Money Flow Index (MFI) ChartAmgen Inc. Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Amgen Inc..

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-01-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-26STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-31STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-02ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-09STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-12MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-13WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-19STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-26ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-27STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-28CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-04ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-06STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-08BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-11RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-12ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-18CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-21SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-03-22CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-27BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-28STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-03DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-04-05WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-04-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-11ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-19CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-23WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-24SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-04-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-29CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-30DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-05-02MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-05-03BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-05-06STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-05-07RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-05-09STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-05-10ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-05-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-15STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-05-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-21STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-05-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-23MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-05-27SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-05-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-05-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-05-30BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-05-31DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-06-03CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-06-07STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-06-10STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-06-12STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-06-14DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.

6.3. Candlestick Patterns

Amgen Inc. Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Amgen Inc. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5048.715
Ma 20Greater thanMa 50281.178
Ma 50Greater thanMa 100271.205
Ma 100Greater thanMa 200267.623
OpenGreater thanClose277.850
Total3/5 (60.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Amgen Inc. with someone you think should read this too:
  • Are you bullish or bearish on Amgen Inc.? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Amgen Inc.? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Amgen Inc.

I send you an email if I find something interesting about Amgen Inc..


Comments

How you think about this?

Leave a comment

Stay informed about Amgen Inc..

Receive notifications about Amgen Inc. in your mailbox!